Impax Asset Management Group plc lessened its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 58.5% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 285,577 shares of the biopharmaceutical company’s stock after selling 402,674 shares during the quarter. Impax Asset Management Group plc’s holdings in […]
Parallel Advisors LLC decreased its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 6.3% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 60,113 shares of the biopharmaceutical company’s stock after selling 4,068 shares during the quarter. Parallel Advisors LLC’s holdings in Bristol-Myers Squibb were worth $3,844,000 as of its most recent […]
Atria Investments Inc increased its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 4.8% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 160,279 shares of the biopharmaceutical company’s stock after acquiring an additional 7,402 shares during the period. Atria Investments Inc’s holdings […]
American International Group Inc. boosted its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 0.4% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 562,489 shares of the biopharmaceutical company’s stock after purchasing an additional 2,160 shares during the period. American International Group Inc.’s holdings in Bristol-Myers […]
Sandy Spring Bank cut its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 1.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 119,472 shares of the biopharmaceutical company’s stock after selling 2,350 shares during the period. Sandy Spring Bank’s […]